Division of Gastroenterology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Division of Gastroenterology, Department of Medicine, Panyananthaphikkhu Chonprathan Medical Center, Srinakharinwirot University, Nonthaburi, Thailand.
Liver Int. 2023 Dec;43(12):2713-2726. doi: 10.1111/liv.15758. Epub 2023 Oct 7.
The heritability of nonalcoholic fatty liver disease (NAFLD) in lean individuals is undetermined. This familial aggregation study aimed to evaluate familial linkage for NAFLD and the risk of NAFLD among first-degree relatives of probands with lean NAFLD.
This study prospectively recruited cohorts of probands with lean NAFLD, probands with obese NAFLD, and lean probands with non-NAFLD and their respective first-degree relatives. A total of 257 participants were evaluated for liver steatosis, defined by the controlled attenuation parameter ≥288 dB/m , metabolic characteristics, and the PNPLA3, TM6SF2, and MBOAT7 polymorphisms.
The prevalence of NAFLD in first-degree relatives of lean NAFLD probands (39.9%) was similar to that in the obese NAFLD group (36.9%) and was significantly higher than in lean persons without NAFLD (19.1%). First-degree relatives of probands with NAFLD who were male, and had central obesity, hypertriglyceridaemia, insulin resistance, and the PNPLA3 rs738409C>G allele had a significantly higher prevalence of NAFLD. After multivariable adjustment for gender, metabolic characteristics, and the PNPLA3 rs738409C>G allele, first-degree relatives of probands with lean NAFLD (odds ratio [OR], 5.13; 95% CI, 1.77-14.86) and obese NAFLD (OR, 3.20; 95% CI, 1.14-8.99) exhibited an increased risk of NAFLD compared with those of lean controls without NAFLD.
Our well-phenotype cohorts revealed familial clustering of NAFLD and higher risks of NAFLD in first-degree relatives of probands with lean or obese NAFLD. The findings encourage clinicians caring for NAFLD patients to be more vigilant for NAFLD in their family members.
瘦人非酒精性脂肪性肝病(NAFLD)的遗传度尚未确定。本项家族聚集研究旨在评估瘦人 NAFLD 患者一级亲属中 NAFLD 的家族连锁性以及患 NAFLD 的风险。
本研究前瞻性招募了瘦人 NAFLD 患者、肥胖人 NAFLD 患者、瘦人非 NAFLD 患者及其相应一级亲属的队列。共有 257 名参与者接受了肝脏脂肪变性的评估,定义为受控衰减参数≥288dB/m,代谢特征以及 PNPLA3、TM6SF2 和 MBOAT7 多态性。
瘦人 NAFLD 患者一级亲属中 NAFLD 的患病率(39.9%)与肥胖人 NAFLD 组(36.9%)相似,且显著高于瘦人非 NAFLD 组(19.1%)。NAFLD 患者一级亲属中男性、中心性肥胖、高三酰甘油血症、胰岛素抵抗和 PNPLA3 rs738409C>G 等位基因与 NAFLD 的患病率显著升高有关。在对性别、代谢特征和 PNPLA3 rs738409C>G 等位基因进行多变量调整后,与瘦人非 NAFLD 对照组相比,瘦人 NAFLD 患者(比值比[OR],5.13;95%可信区间[CI],1.77-14.86)和肥胖人 NAFLD 患者(OR,3.20;95%CI,1.14-8.99)的一级亲属患 NAFLD 的风险增加。
我们的表型良好的队列显示 NAFLD 的家族聚集性以及瘦人或肥胖人 NAFLD 患者一级亲属中 NAFLD 的更高风险。这些发现鼓励照顾 NAFLD 患者的临床医生更加警惕其家庭成员中的 NAFLD。